Fig. 1From: Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseasesKaplan-Meier Survival Curve for the time of onset of rituximab-associated hypogammaglobulinemia the time of onset. Most subjects had low Immunoglobulin gamma (IgG) with the first six months of treatment. This difference was statistically significant using the Log-rank test (Mantel-Cox test) p-value = 0.02Back to article page